Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:40 PM ET Form 4
Insider Buying Super Micro Computer, Inc. SMCI

Super Micro Computer Insider Scott Angel Buys $49.9K of Stock

Scott Angel bought 1,715 shares of Super Micro Computer, Inc. at $29.12 a share, worth $49.9K in total on Nov 6, 2026. Shares held after the trade: 8,770 (+24.3%).

Value
$49.9K
Shares
1,715
Price
$29.12
Holding change
+24.3%
Trade date
Nov 6, 2026
4:39 PM ET Form 4
Insider Selling Host Hotels & Resorts, Inc. HST

Host Hotels & Resorts President and CEO James F. Risoleo Sells $16.7M of Stock

James F. Risoleo, President and CEO, sold 659,574 shares of Host Hotels & Resorts, Inc. at $25.36 a share, worth $16.7M in total on Nov 9, 2026. Shares held after the trade: 2,436,460 (-21.3%).

Value
$16.7M
Shares
659,574
Price
$25.36
Role
President and CEO
Holding change
-21.3%
Trade date
Nov 9, 2026
4:39 PM ET Form 4
Insider Selling Host Hotels & Resorts, Inc. HST

Host Hotels & Resorts EVP, CFO Sourav Ghosh Sells $2.32M of Stock

Sourav Ghosh, EVP, CFO, sold 93,863 shares of Host Hotels & Resorts, Inc. at $24.76 a share, worth $2.32M in total on Nov 6, 2026. Shares held after the trade: 418,147 (-18.3%).

Value
$2.32M
Shares
93,863
Price
$24.76
Role
EVP, CFO
Holding change
-18.3%
Trade date
Nov 6, 2026
4:39 PM ET 10-Q
Financial Results Inhibikase Therapeutics, Inc. IKT

Inhibikase Therapeutics Q3 2026 Results: Net Loss of $20.5M, Loss Widens

Inhibikase Therapeutics reported a significant increase in total assets to $201.8 million as of September 30, 2026, driven by a substantial rise in marketable securities. The company's accumulated deficit grew to $199.1 million, reflecting ongoing research and development investments, while common stock outstanding increased to 140,269,633 shares.

Key figure
Net loss $20.5M
4:39 PM ET Form 4
Insider Selling Host Hotels & Resorts, Inc. HST

Host Hotels & Resorts Insider Mary Baglivo Sells $404K of Stock

Mary Baglivo sold 16,429 shares of Host Hotels & Resorts, Inc. at $24.35 to $25.35 a share (average $24.60) in 3 transactions, worth $404K in total between Nov 6, 2026 and Nov 9, 2026. Shares held after the trade: 2 (-99.9%).

Value
$404K
Shares
16,429
Average price
$24.60
Holding change
-99.9%
Trade date
Nov 6, 2026 to Nov 9, 2026
4:38 PM ET 8-K
Shareholder Meeting Broadridge Financial Solutions, Inc. BR

Broadridge Financial Solutions Shareholder Meeting

Broadridge Financial Solutions held its 2026 Annual Meeting of Stockholders on November 10, 2026. Stockholders elected 10 directors for one-year terms, approved executive compensation in an advisory 'Say on Pay' vote, and ratified Deloitte & Touche LLP as the independent auditor for fiscal year 2027.

4:37 PM ET 8-K
Financial Results Evolution Petroleum Corp EPM

Evolution Petroleum Financial Results

Evolution Petroleum reported fiscal first quarter 2027 results with revenue of $22.6 million, driven by higher realized oil and NGL prices. The company reported a net loss of $3.0 million but highlighted that its recently acquired Permian Minerals portfolio exceeded production expectations. Additionally, the board declared its 53rd consecutive quarterly cash dividend of $0.12 per share.

Term
Q1 2027

“We are encouraged by our fiscal first quarter results and excited about the outlook for our diversified portfolio, particularly the increasing contributions from our growing mineral and royalty interests.”

Kelly Loyd, President and Chief Executive Officer

“Our recently acquired Permian Minerals exceeded production expectations, and our late fiscal 2026 acquisitions of Haynesville and Bossier Shale minerals and royalties are contributing in line with expectations as new wells enter production.”

Kelly Loyd, President and Chief Executive Officer
4:37 PM ET 10-Q
Financial Results North Haven Private Income Fund LLC

North Haven Private Income Fund Q3 2026 Results: Net Income $17.8M, Down 73.6% YoY

For the nine months ended September 30, 2026, North Haven Private Income Fund LLC reported total investment income of $446.7 million and net investment income of $199.4 million. The fund experienced a net decrease in members' capital of $433.0 million during the period, primarily driven by $476.9 million in unit repurchases and $159.9 million in net realized and unrealized losses.

Key figure
Net income $17.8M · -73.6% YoY
4:37 PM ET 10-Q
Financial Results Fortress Private Lending Fund

Fortress Private Lending Fund Q3 2026 Results: Net Income $26.8M, Up 200.6% YoY

For the nine months ended September 30, 2026, Fortress Private Lending Fund reported total investment income of $134.0 million and net investment income of $72.3 million. Total net assets grew to $1.14 billion, driven by $279.5 million in share issuances, despite a net realized loss of $26.3 million primarily from non-controlled investments.

Key figure
Net income $26.8M · +200.6% YoY
4:37 PM ET 8-K
Capital Raise Senti Biosciences Holdings, Inc. SNTI

Senti Biosciences Holdings Capital Raise

Senti Biosciences entered into an equity commitment letter with CPIF II-9 Limited, an affiliate of Celadon Partners, for the purchase of up to $4.55 million of common stock. The commitment is structured to be funded in quarterly tranches through December 31, 2027, at a price per share based on Nasdaq's Minimum Price definition. The company also agreed to provide the investor with customary demand and piggyback registration rights for the shares issued.

Counterparty
CPIF II-9 Limited
Term
through Dec 2027
4:36 PM ET Form 4
Insider Selling Motorola Solutions, Inc. MSI

Motorola Solutions SVP, Strategy & Ventures Rajan Naik Sells $5.13M of Stock

Rajan Naik, SVP, Strategy & Ventures, sold 10,005 shares of Motorola Solutions, Inc. at $511.43 to $512.68 a share (average $512.43) in 2 transactions, worth $5.13M in total on Nov 6, 2026. Shares held after the trade: 12,563 (-13.6%).

Value
$5.13M
Shares
10,004
Average price
$512.43
Role
SVP, Strategy & Ventures
Holding change
-13.6%
Trade date
Nov 6, 2026
4:36 PM ET 8-K
Financial Results iBio, Inc. IBIO

iBio Financial Results

iBio reported financial results for its first fiscal quarter of 2027, highlighting a revenue increase to $1.1 million compared to $0.1 million in the prior year. The company advanced its obesity pipeline, completing dosing in the SAD portion of its Phase 1 trial for IBIO-600 and presenting preclinical data for IBIO-610 showing improved fat-selective weight loss in combination with GLP-1 therapy.

Term
Q1 2027

“This was a quarter of focus and execution as we advanced our portfolio of long-acting antibody therapeutics designed to address important challenges in obesity care. The data presented at EASD strengthen our conviction in IBIO-610’s potential to deliver high-quality weight loss and provide important preclinical validation as we advance toward an IND-equivalent filing by the end of 2026, with plans to initiate first-in-human studies in the first half of 2027.”

Martin Brenner, DVM, Ph.D., Chief Executive Officer and Chief Scientific Officer
4:36 PM ET 8-K
Capital Raise World Omni Auto Receivables Trust 2026-D

World Omni Auto Receivables Trust 2026-D Capital Raise of $971M

World Omni Auto Receivables Trust 2026-D entered into an underwriting agreement to issue $970.86 million in asset-backed notes. The offering includes multiple classes of notes (Class A-1 through Class C) secured by motor vehicle retail installment sale contracts. The notes are expected to be issued on November 18, 2026, with Truist Securities, Mizuho, TD Securities, and Wells Fargo acting as representatives for the underwriters.

Value
$971M
Counterparty
Truist Securities, Inc.
4:36 PM ET Form 4
Insider Selling United Therapeutics Corp UTHR

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $944K of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 1,614 shares of United Therapeutics Corp at $583.80 to $585.63 a share (average $584.59) in 3 transactions, worth $944K in total on Nov 9, 2026. Shares held after the trade: 324,443 (-0.1%).

Value
$944K
Shares
1,614
Average price
$584.59
Role
Chairperson & CEO
Holding change
-0.1%
Trade date
Nov 9, 2026
4:36 PM ET 8-K
Nasdaq/NYSE Compliance Notice Nextnrg, Inc. NXXT

Nextnrg Nasdaq/NYSE Compliance Notice

NextNRG, Inc. received notice that the Nasdaq Hearings Panel denied its request to continue its listing on Nasdaq due to failure to meet the $1.00 minimum bid price and $35 million market value requirements. Trading of the company's common stock will be suspended on November 11, 2026, and is expected to transition to the OTC Markets under the symbol 'NXXT'.

Counterparty
The Nasdaq Stock Market LLC
4:36 PM ET 8-K
Financial Results Angel Studios, Inc. ANGX

Angel Studios Financial Results

Angel Studios reported Q3 2026 revenue of $159.0 million, a 107.7% year-over-year increase driven by the success of 'Young Washington' and growth in its Angel Guild membership to 2.94 million paying members. The company significantly reduced its net loss to $5.2 million and generated positive operating cash flow of $10.3 million. Management reiterated its full-year 2026 guidance for an Adjusted EBITDA loss of less than $25 million.

Term
Q3 2026

“Our model continues to show results, surpassing analyst expectations. Q3 revenue more than doubled year-over-year to $159 million, and we added approximately 335,000 net new members in the quarter to reach 2.94 million paying Guild members, while the rest of the US subscription video on demand (SVOD) industry lost 1.7 million subscribers, according to Antenna*.”

Neal Harmon, CEO

“The Angel team has more than doubled revenue in our first year as a publicly listed company. But we have greater ambitions than that. I am reminded of a quote from Cabrini, “The world is too small for what [we] intend to do.””

Neal Harmon, CEO
4:36 PM ET 8-K
Capital Raise Golden Minerals Co AUMN

Golden Minerals Capital Raise

Golden Minerals completed a non-brokered private placement of 17.8 million units for gross proceeds of C$5.0 million. Each unit consists of one common share and one-half of a purchase warrant exercisable at C$0.45. Proceeds will fund exploration programs at the Desierto project in Argentina and general working capital through 2027.

4:36 PM ET 8-K
Financial Results Datacentrex, Inc. DTCX

Datacentrex Financial Results

Datacentrex reported Q3 2026 financial results, achieving a positive Adjusted EBITDA of $1.3 million compared to a loss in the prior quarter. The company also highlighted a $30 million strategic investment in Eagle LNG to gain exposure to energy infrastructure and space propulsion markets. As of quarter-end, the company maintained $29.3 million in cash and digital assets with zero debt.

Counterparty
Eagle LNG
Term
Q3 2026

“Third-quarter Adjusted EBITDA was positive at approximately $1.3 million, including $2.2 million of net realized and unrealized gains on digital assets. We also maintained substantial liquidity following our $30 million investment in Eagle LNG, ending September with approximately $29.3 million in cash and digital assets, including $27.5 million in cash, and no outstanding debt.”

Parker Scott, Chief Executive Officer

“Our $30 million investment in Eagle LNG gives us an ownership position in an operating energy business with established infrastructure and customers under long-term supply agreements. As we approach 2027, we believe Eagle’s marine and Caribbean energy business provides a foundation for growth, while its ability to supply aerospace-specification liquid methane creates additional opportunity as the next generation of commercial launch vehicles enters service and scales.”

Parker Scott, Chief Executive Officer
4:36 PM ET 10-Q
Financial Results Corbus Pharmaceuticals Holdings, Inc. CRBP

Corbus Pharmaceuticals Holdings Q3 2026 Results: Net Loss of $37.8M, Loss Widens

Corbus Pharmaceuticals reported a net loss of $95.8 million for the nine months ended September 30, 2026, driven by a significant increase in research and development expenses related to its ADC and obesity pipelines. The company's cash and investment position decreased to approximately $115.3 million from $163.3 million at the end of 2025, despite raising $27.6 million through common stock issuances.

Key figure
Net loss $37.8M
4:35 PM ET 8-K
Financial Results Stran & Company, Inc. SWAG

Stran & Company Financial Results

Stran & Company reported Q3 2026 revenue of $28.1 million, an 8.2% increase year-over-year, and achieved a net income of $35,000 compared to a loss in the prior-year period. The company saw significant margin expansion to 33.3%, driven largely by its Stran Loyalty Solutions segment. For the first nine months of 2026, the company generated $1.1 million in net income and $1.8 million in positive operating cash flow.

Term
Q3 2026

“Our third-quarter results reflect the progress we are making in building a stronger, more profitable business. Revenue grew 8.2% to $28.1 million, gross profit increased 32.4% to $9.4 million, and gross margin expanded by approximately 610 basis points to 33.3%.”

Andy Shape, Chief Executive Officer of Stran

“Looking ahead, our focus remains on translating revenue growth into stronger earnings and cash flow, while maintaining the financial flexibility to pursue new customer opportunities and strategic growth initiatives.”

Andy Shape, Chief Executive Officer of Stran
4:35 PM ET Form 4
Insider Selling United Therapeutics Corp UTHR

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $4.52M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 7,886 shares of United Therapeutics Corp at $556.52 to $582.79 a share (average $572.69) in 24 transactions, worth $4.52M in total on Nov 9, 2026. Shares held after the trade: 326,057 (-0.5%).

Value
$4.52M
Shares
7,886
Average price
$572.69
Role
Chairperson & CEO
Holding change
-0.5%
Trade date
Nov 9, 2026
4:35 PM ET 10-Q
Financial Results Big Sky Industrial Inc. BSIN

Big Sky Industrial Q3 2026 Results: Net Loss of $3.5M, Loss Widens

Big Sky Industrial Inc. reported a net loss of $9.0 million for the nine months ended September 30, 2026, compared to a $12.5 million loss in the prior year period. The company significantly increased its unproved industrial gas properties to $42.5 million and expanded its common stock outstanding to 52.5 million shares following an underwritten offering.

Key figure
Net loss $3.5M
4:35 PM ET Form 4
Insider Selling CME Group Inc. CME

CME Group Insider Daniel G. Kaye Sells $162K of Stock

Daniel G. Kaye sold 532 shares of CME Group Inc. at $304.17 a share, worth $162K in total on Nov 9, 2026. Shares held after the trade: 4,313 (-11.0%).

Value
$162K
Shares
532
Price
$304.17
Holding change
-11.0%
Trade date
Nov 9, 2026
4:34 PM ET Form 4
Insider Selling Motorola Solutions, Inc. MSI

Motorola Solutions SVP, General Counsel James A. Niewiara Sells $1.18M of Stock

James A. Niewiara, SVP, General Counsel, sold 2,266 shares of Motorola Solutions, Inc. at $515.16 to $522.35 a share (average $521.77) in 2 transactions, worth $1.18M in total between Nov 6, 2026 and Nov 9, 2026. Shares held after the trade: 18,398 (-10.2%).

Value
$1.18M
Shares
2,266
Average price
$521.77
Role
SVP, General Counsel
Holding change
-10.2%
Trade date
Nov 6, 2026 to Nov 9, 2026
4:34 PM ET 10-Q
Financial Results Vinebrook Homes Trust, Inc.

Vinebrook Homes Trust Q3 2026 Results: Net Loss of $39.3M, Loss Narrows

VineBrook Homes Trust, Inc. reported a significant increase in real estate held for sale, rising from $91.5 million at the end of 2025 to $239.9 million as of September 30, 2026, as part of a strategy to sell approximately 2,725 homes to satisfy upcoming debt obligations. The company's total net real estate investments decreased to $2.65 billion, and it faces new regulatory risks from the 21st Century ROAD to Housing Act enacted in July 2026.

Key figure
Net loss $39.3M
4:34 PM ET 8-K
Other 8-K Filing Central Pacific Financial Corp CPF

Central Pacific Financial Other 8-K Filing

Central Pacific Financial Corp. announced a temporary blackout period for its directors and executive officers from December 18 to December 24, 2026. The restriction is due to the removal and liquidation of the company's stock fund as an investment option within the Central Pacific Bank 401(k) Retirement Savings Plan. During this window, covered persons are prohibited from trading in the company's common stock or derivative securities.

Term
Dec 18-24, 2026
4:34 PM ET 8-K
Financial Results Fortitude Gold Corp FTCO

Fortitude Gold Financial Results

Fortitude Gold reported third quarter 2026 net sales of $10.3 million and net income of $2.0 million, or $0.07 per share. The company produced 2,139 gold ounces during the period and maintained a cash balance of $8.5 million while continuing permitting efforts for its Golden Mile property.

Term
3 months

“We had a very busy and productive third quarter including the ongoing expansion of our heap leach pad.”

Jason Reid, CEO and President
4:34 PM ET Form 4
Insider Selling United Therapeutics Corp UTHR

United Therapeutics Director Christopher Patusky Sells $702K of Stock

Christopher Patusky, Director, sold 1,210 shares of United Therapeutics Corp at $580.00 a share, worth $702K in total on Nov 9, 2026. Shares held after the trade: 2,140 (-36.1%).

Value
$702K
Shares
1,210
Price
$580.00
Role
Director
Holding change
-36.1%
Trade date
Nov 9, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.